I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Vetter, Thorsten
75
results:
Format
Online (75)
Mediatypes
Articles (Online) (30)
Bookchapter (Online) (8)
OpenAccess-fulltext (37)
Languages
english (55)
german (4)
Sorted by: Relevance
Sorted by: Year
?
1
Patient‐reported, observer‐reported and performance outcome..:
Silva, Marcio
;
Moseley, Jane
;
Vetter, Thorsten
...
British Journal of Clinical Pharmacology. 90 (2023) 1 - p. 299-312 , 2023
Link:
https://doi.org/10.1111/..
?
2
EMA-FDA Parallel Scientific Advice: Optimizing Development ..:
Thor, Shannon
;
Vetter, Thorsten
;
Marcal, Anabela
.
Therapeutic Innovation & Regulatory Science. 57 (2023) 4 - p. 656-661 , 2023
Link:
https://doi.org/10.1007/..
?
3
Evolving regulatory perspectives on digital health technolo..:
Colloud, Seya
;
Metcalfe, Thomas
;
Askin, Scott
...
npj Digital Medicine. 6 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
4
Biomarker Qualification at the European Medicines Agency: A..:
Bakker, Elisabeth
;
Hendrikse, Natalie M.
;
Ehmann, Falk
...
Clinical Pharmacology & Therapeutics. 112 (2022) 1 - p. 69-80 , 2022
Link:
https://doi.org/10.1002/..
?
5
Biomarkers in Medicines Development—From Discovery to Regul..:
Hendrikse, Natalie M.
;
Llinares Garcia, Jordi
;
Vetter, Thorsten
..
Frontiers in Medicine. 9 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
6
Perspectives on a Way Forward to Implementation of Precisio..:
Bakker, Elisabeth
;
Mol, Peter G. M.
;
Nabais, João
...
Frontiers in Pharmacology. 12 (2021) - p. , 2021
Link:
https://doi.org/10.3389/..
?
7
Change in Albuminuria and Estimated GFR as End Points for C..:
Holtkamp, Frank
;
Gudmundsdottir, Hrefna
;
Maciulaitis, Romaldas
...
American Journal of Kidney Diseases. 75 (2020) 1 - p. 6-8 , 2020
Link:
https://doi.org/10.1053/..
?
8
Multistakeholder Advice at the European Medicines Agency: I..:
Vamvakas, Spiros
;
Moseley, Jane
;
Vetter, Thorsten
Clinical Pharmacology & Therapeutics. 105 (2019) 4 - p. 819-821 , 2019
Link:
https://doi.org/10.1002/..
?
9
Marketing authorisation of orphan medicines in Europe from ..:
Hofer, Matthias P.
;
Hedman, Hanna
;
Mavris, Maria
...
Drug Discovery Today. 23 (2018) 2 - p. 424-433 , 2018
Link:
https://doi.org/10.1016/..
?
10
GFR Decline as an End Point for Clinical Trials in CKD: A V..:
Mol, Peter G.M.
;
Maciulaitis, Romaldas
;
Vetter, Thorsten
American Journal of Kidney Diseases. 64 (2014) 6 - p. 838-840 , 2014
Link:
https://doi.org/10.1053/..
?
11
Adaptive clinical trial designs for European marketing auth..:
Elsäßer, Amelie
;
Regnstrom, Jan
;
Vetter, Thorsten
...
Trials. 15 (2014) 1 - p. , 2014
Link:
https://doi.org/10.1186/..
?
12
Formation of a Ternary Complex among NHERF1, β-Arrestin, an..:
Klenk, Christoph
;
Vetter, Thorsten
;
Zürn, Alexander
...
Journal of Biological Chemistry. 285 (2010) 39 - p. 30355-30362 , 2010
Link:
https://doi.org/10.1074/..
?
13
Reverse Engineering of Digital Measures: Inviting Patients ..:
Clay, Ieuan
;
Peerenboom, Nele
;
Connors, Dana E
...
volume:7. , 2023
Link:
https://hdl.handle.net/1..
?
14
Reverse Engineering of Digital Measures: Inviting Patients ..:
Mueller, Arne
;
Nam, Julian
;
Ng, Wan Fai
...
info:eu-repo/semantics/altIdentifier/doi/10.1159/000530413. , 2023
Link:
https://hdl.handle.net/2..
?
15
Biomarker qualification at the European Medicines Agency: a..:
Bakker, Elisabeth
;
Hendrikse, Natalie M
;
Ehmann, Falk
...
https://research.rug.nl/en/publications/3eaa0206-2d28-417c-a0a2-9f05958a2cb7. , 2022
Link:
https://hdl.handle.net/1..
1-15